GENETIC VARIATION IN THE DDAH-1 GENE IN RELATION TO ADMA LEVELS AND ENDOTHELIAL FUNCTIONJOURNAL OF HYPERTENSIONIF4.12010-06-010PREAI
Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation The Mechanisms for the Diabetes Preventing Effect of Candesartan (MEDICA) StudyHYPERTENSIONIF8.22008-12-01110OAAI
The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism:: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) trialAMERICAN JOURNAL OF HYPERTENSIONIF3.12008-07-0116OAAI
Using genotyping to predict responses to anti-hypertensive treatmentTRENDS IN PHARMACOLOGICAL SCIENCESIF19.92005-08-0118PREAI
Hypertension and SNP genotyping in antihypertensive treatmentCARDIOVASCULAR TOXICOLOGYIF3.72005-01-0112PREAI
Single nucleotide polymorphisms predict the change in left ventricular mass in response to anti hypertensive treatmentJOURNAL OF HYPERTENSIONIF4.12004-12-0129PREAI
B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment:: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trialJOURNAL OF HYPERTENSIONIF4.12003-03-0127PREAI
The CYP2C9 genotype predicts the blood pressure response to irbesartan:: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trialJOURNAL OF HYPERTENSIONIF4.12002-10-0177PREAI
Aldosterone synthase (CYP11B2)-344 C/T polymorphism is related to antihypertensive responseAMERICAN JOURNAL OF HYPERTENSIONIF3.12002-05-0170OA
Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during anti hypertensive treatment:: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trialJOURNAL OF HYPERTENSIONIF4.12002-04-0162PREAI
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patientsJOURNAL OF HYPERTENSIONIF4.12001-10-01124PREAI
ACE-gene polymorphism predicts blood pressure response to AT1-receptor antagonist treatment in hypertensive patientsJOURNAL OF HYPERTENSIONIF4.12000-06-010PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向